share_log

Cardinal Health (NYSE:CAH) Stock Performs Better Than Its Underlying Earnings Growth Over Last Three Years

Cardinal Health (NYSE:CAH) Stock Performs Better Than Its Underlying Earnings Growth Over Last Three Years

卡地納健康(紐交所:CAH)股票在過去三年中的表現優於其基本盈利增長
Simply Wall St ·  11/03 20:25

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. For instance the Cardinal Health, Inc. (NYSE:CAH) share price is 134% higher than it was three years ago. How nice for those who held the stock! On top of that, the share price is up 18% in about a quarter. But this move may well have been assisted by the reasonably buoyant market (up 10% in 90 days).

在任何一隻股票上,您的最大虧損(假設您不使用槓桿)可以達到您的資金的100%。但當您選擇一家真正蓬勃發展的公司時,您可以獲得超過100%的回報。例如,卡地納健康(NYSE:CAH)的股價比三年前上漲了134%。對於持有該股票的人來說是多麼美好!除此之外,股價在一個季度內上漲了18%。但這種漲幅很可能是受到相當繁榮的市場的推動(90天內上漲了10%)。

The past week has proven to be lucrative for Cardinal Health investors, so let's see if fundamentals drove the company's three-year performance.

過去一週對卡地納健康的投資者來說是有利可圖的,讓我們看看是什麼基本因素推動了公司在過去三年內的表現。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

儘管市場是一個強大的價格機制,但股票價格反映的不僅是潛在業務績效,還反映了投資者的情緒。 了解市場情緒隨時間的變化的一種方法是查看公司的股價與每股收益(EPS)之間的互動。

During three years of share price growth, Cardinal Health achieved compound earnings per share growth of 11% per year. This EPS growth is lower than the 33% average annual increase in the share price. This suggests that, as the business progressed over the last few years, it gained the confidence of market participants. It's not unusual to see the market 're-rate' a stock, after a few years of growth.

在股價增長的三年裏,卡地納健康實現了每年11%的複合每股收益增長。這種每股收益增長低於股價年均增長33%的平均水平。這表明,隨着企業在過去幾年裏的進展,它贏得了市場參與者的信心。在股價經歷幾年增長後,看到市場對一支股票進行「重新定價」並不罕見。

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

您可以在下面的圖片中查看每股收益如何隨時間變化(單擊圖表以查看確切的價值)。

big
NYSE:CAH Earnings Per Share Growth November 3rd 2024
紐交所: 卡地納健康2024年11月3日每股收益增長

We know that Cardinal Health has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.

我們知道卡地納健康最近改善了其底線,但它的營業收入會增長嗎?如果您感興趣,可以查看這份顯示共識營業收入預測的免費報告。

What About Dividends?

那麼分紅怎麼樣呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Cardinal Health, it has a TSR of 153% for the last 3 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return.

除了衡量股價回報外,投資者還應考慮總股東回報率(TSR)。TSR包括任何分拆或折讓的資本募集價值,以及任何分紅,基於分紅再投的假設。因此,對於支付豐厚分紅的公司,TSR往往要比股價回報高得多。以卡地納健康爲例,過去3年其TSR爲153%。這超過了前面提到的股價回報。公司支付的分紅因此提高了總股東回報。

A Different Perspective

不同的觀點

Cardinal Health shareholders are up 18% for the year (even including dividends). But that was short of the market average. It's probably a good sign that the company has an even better long term track record, having provided shareholders with an annual TSR of 20% over five years. Maybe the share price is just taking a breather while the business executes on its growth strategy. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - Cardinal Health has 2 warning signs we think you should be aware of.

卡地納健康股東今年的回報率爲18%(包括分紅)。但這低於市場平均水平。也許更值得關注的是,公司具有更好的長期業績記錄,爲股東提供了年均20%的TSR五年。也許股價只是在公司執行增長策略時稍事歇息。雖然值得考慮市場狀況對股價的影響,但還有更重要的因素。例如,承擔風險-卡地納健康存在 2個警示跡象 我們認爲您應該注意。

For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket.

對於那些喜歡尋找獲勝投資的人來說,最近有內部購買的低估公司免費列表可能是一個很好的選擇。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論